No Widgets found in the Sidebar

Emapalumab by Swedish Orphan Biovitrum for Systemic-Onset Juvenile Idiopathic Arthritis …

  ​According to GlobalData, Phase III drugs for Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) have an 89% phase transition success rate ( ...  According to GlobalData, Phase III drugs for Systemic-Onset…

Read More

CMPS and Juvenile Idiopathic Arthritis: A Diagnostic Prediction Model – Physician’s Weekly

  ​The following is a summary of "A Diagnostic Prediction Model for Separating Juvenile Idiopathic Arthritis and Chronic Musculoskeletal Pain ...  The following is a summary of "A Diagnostic Prediction Model…

Read More